Hypertension and hyperlipidemia are among major risk factors for ischemic heart disease, the principal human killer worldwide. In addition, they form important components of the well-established metabolic syndrome [1,2]. Generally speaking, dyslipidemia comprises abnormality in the level of triglyceride, HDL-cholesterol and LDL-cholesterol [3]. The description of hypertension and dyslipidemia as a single entity under the title “dyslipidemic hypertension (DH)” has emerged in medical literatures since 1988 [4]; a suggestion was made at that time as being a genetic syndrome to explain the coexistence of dyslipidemia and essential hypertension in a subset of patients [5]; however, sporadic forms of DH are far more frequent than familial ones [1]. It has beenreported that in addition to hypertension, another cardiovascularrisk factor is present in the majority of hypertensive patients and that hyperlipidemia forms substantial proportion of these additional risk factors [6].
CITATION STYLE
Abdalsahib Al Zamili, A. F. (2019). The Coexistence of Hypertension and Dyslipidemia in a Cohort of Iraqi patients with essential Hypertension: Cross Sectional Study. American Journal of Biomedical Science & Research, 3(1), 15–18. https://doi.org/10.34297/ajbsr.2019.03.000626
Mendeley helps you to discover research relevant for your work.